Virginia Kaklamani

Statistics

Publications

105

Citations

14.2K

H-Index

Active since

1997

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Northwestern University

Harvard University

Dana-Farber Cancer Institute

The University of Texas Health Science Center at Houston

Virginia Kaklamani is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and breast oncology.

ORCID

Publications per year

1997–2024

105

Publications

105

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.4K citations · Full text

Medicine, Endocrinology, Oncology +17

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Oncology, Breast Oncology +16

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

Yi-Zhou Jiang, Ding Ma, Chen Suo et al. · Cancer Cell · 2019 · 1.1K citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

François‐Clément Bidard, Virginia Kaklamani, Patrick Neven et al. · Journal of Clinical Oncology · 2022 · 695 citations · Full text

Medicine, Oncology, Pharmacology +15

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

Elaine F. Remmers, Fulya Coşan, Yohei Kirino et al. · Nature Genetics · 2010 · 676 citations · Full text

Life Sciences, Genetics, Immunology +16

1–5 of 105